When Competitors Collaborate, Who Wins? We All Do

Health System Innovation and Policy expert Rena Conti on the historic COVID-19 vaccine deal between Merck and Johnson & Johnson

In a White House–brokered deal, business rivals Merck and Johnson & Johnson will partner to manufacture the latter’s COVID-19 vaccine. Photo by Alex Gottschalk/DeFodi Images via Getty Images

BU Today: Were you surprised by the two companies’ agreement?

Merck made a previous collaboration with Pfizer, correct?

How do you think Merck might be reimbursed for helping J&J, and are there risks to collaboration, such as loss of proprietary information between two former competitors?

Do you see this happening more? Are cooperative agreements between competitors a trend, and why?

Cutting-edge research and commentary out of Boston University, home to Nobel laureates, Pulitzer winners and Guggenheim Scholars. Find an expert: bu.edu/experts

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store